Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAG1C: Exenatide for Glycaemic Control in Type 1 Diabetes
NCT03017352Phase 2Completed
- Start
- Dec 2016
- Primary completion
- Jun 2019
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of exenatide in type 1 diabetes mellitus (T1D). Started Dec 2016; status: completed.
02
Drugs
exenatide
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT03017352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03017352.